osteopontin

Osteoprotegerin (OPG) is a secretory glycoprotein that is a family member of the TNF receptor (TNFR) superfamily. Osteoprotegerin protects bone by blocking osteoclastogenesis and increasing bone density. Unlike other TNFRs, osteoprotegerin lacks a transmembrane domain as well as any apparent cell-associated signals. High levels of osteoprotegerin mRNA are found in specialized tissues such as lung, heart, kidney, and placenta. There is evidence that osteoprotegerin plays a role in degenerative arterial disease.

Bone and dentin are closely related tissues, formed when a type I collagen-rich extracellular matrix (ECM) is secreted from the osteoblasts or odontoblasts and subsequently mineralized. This process is tightly regulated by type I collagen plus a number of non-collagenous proteins, including members of the SIBLING (Small Integrin-Binding LIgand, N-linked Glycoprotein) family.

Antibody suppliers, such as us at Novus Biologicals, supply a wide range of cell marker products, among them the Osteopontin antibody. Recently, the osteopontin antibody has proven useful in hepatic cancer research.

Osteopontin (OPN) is mainly expressed by the osteoblasts; its primary function is in the mineralization of bone. However, OPN is expressed to a lower degree in other areas of the body, being involved in cell adhesion, cell migration and the inflammatory response.